- $430.67m
- $372.45m
Tocagen: Set for best day on reverse merger deal with Forte Biosciences
Brief: Tocagen And Forte Biosciences Announce Merger
U.S. RESEARCH ROUNDUP-Elastic, Okta, Viasat
Brief: Tocagen Reports Third Quarter 2019 Financial Results
Brief: Tocagen Reports Q3 Loss Per Share $0.78
Brief: Tocagen Says Entered Into Amendment To Its Loan And Security Agreement With Oxford Finance, Silicon Valley Bank
U.S. STOCKS ON THE MOVE-PepsiCo, Tesla, GoPro, Bed Bath & Beyond
U.S. STOCKS ON THE MOVE-regular hours
U.S. STOCKS ON THE MOVE-Pepsi, Tesla, PDS Biotech, GoPro
Tocagen: Plans to trim workforce after brain cancer trial failure
Brief: Tocagen Begins Restructuring Plan That Includes Cutting Workforce By About 65%
-Street View: Tocagen's brain cancer study failure 'significant' setback
NASDAQ RESUMED
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE
U.S. STOCKS ON THE MOVE-Sintx Technologies, Tailored Brands, Tocagen, Celsius Holdings
U.S. STOCKS ON THE MOVE-Sintx Technologies, Tailored Brands, Tocagen, Aurora Cannabis
Tocagen shares plunge as brain cancer treatment fails late-stage trial
Tocagen's brain cancer treatment fails late-stage study, shares slump (updated)
Tocagen's brain cancer treatment fails late-stage study